STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 7th, 2014 • Polaris Venture Partners Iv Lp • Biological products, (no disgnostic substances) • Delaware
STOCK PURCHASE AGREEMENT, dated as of April 2, 2014 (this “Agreement”), is made by and among Celgene Corporation, a Delaware corporation (“Buyer”), and Polaris Venture Partners Entrepreneurs Fund IV, L.P., a Delaware limited partnership, and Polaris Venture Partners IV, L.P., a Delaware limited partnership (collectively, the “Sellers”).
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • April 7th, 2014 • Polaris Venture Partners Iv Lp • Biological products, (no disgnostic substances)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
